A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure

Summary

The primary objective of the study is to compare relative changes in blood N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels after 30 days of treatment in participants with worsening heart failure (WHF), who are treated with either OPC-131461 or placebo.

Timeline

Start

2025-04-30

Primary completion

2025-05-25

Completion

2025-05-25

Outcome

Outcome not reported

Stopped (Enrollment): “No sites were initiated, no sites were activated, no patients were enrolled in this study.”

Drugs

Indications